Matthew Ruth - Jul 19, 2021 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC. (OPNT)

Signature
/s/ Matthew Ruth
Stock symbol
OPNT
Transactions as of
Jul 19, 2021
Transactions value $
$0
Form type
4
Date filed
7/20/2021, 04:09 PM
Next filing
Sep 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Award $0 +15K $0.00 15K Jul 19, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPNT Stock Option (right to buy) Award $0 +50K $0.00 50K Jul 19, 2021 Common Stock 50K $16.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 15,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of July 12, 2022, July 12, 2023, July 12, 2024 and July 12, 2025, subject to the Reporting Person continuing as a service provider through each such date.
F2 On July 19, 2021, the reporting person was granted 50,000 incentive stock options. Each option represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the options vest on the anniversary dates of July 12, 2022, July 12, 2023, July 12, 2024 and July 12, 2025, subject to the Reporting Person continuing as a service provider through such date.